ProjectTalimogene Laherparepvec T-VEC 20110265
Basic data
Title:
Talimogene Laherparepvec T-VEC 20110265
Duration:
01/06/2016 to 31/12/2019
Abstract / short description:
Protokoll 20110265: Multizentrische, offene Studie der Phase 1b/3 mit Talimogene Laherparepvec in Kombination mit Pembrolizumab (MK-3475) zur Behandlung des nicht resezierten Melanoms im Stadium IIIB bis IVM1c (MASTERKEY-265)
Keywords:
melanoma
Melanom
Involved staff
Managers
Department of Dermatology
Hospitals and clinical institutes, Faculty of Medicine
Hospitals and clinical institutes, Faculty of Medicine
Contact persons
Department of Dermatology
Hospitals and clinical institutes, Faculty of Medicine
Hospitals and clinical institutes, Faculty of Medicine
Faculty of Medicine
University of Tübingen
University of Tübingen
Cluster of Excellence: Image-Guided and Functionally Instructed Tumor Therapies (iFIT)
Centers or interfaculty scientific institutions
Centers or interfaculty scientific institutions
Department of Radiology
Hospitals and clinical institutes, Faculty of Medicine
Hospitals and clinical institutes, Faculty of Medicine
Local organizational units
Department of Dermatology
Hospitals and clinical institutes
Faculty of Medicine
Faculty of Medicine
Funders
München, Bayern, Germany